Inovio Pharmaceuticals, Inc.

INO

$1.18

Name : Inovio Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $122,009,072.00

EPSttm : -1.03

Inovio Pharmaceuticals, Inc.

$1.18

2.48%

$0.03

INO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

19.34

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

-0.11

EPS Last/This Y

1.08

EPS This/Next Y

0.29

Price

1.18

Target Price

3.17

Analyst Recom

1.67

Performance Q

7.27

Upside

-3,600.0%

Beta

1.61

Ticker: INO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	INO	1.28	0.03	0.04	104941
2026-08-31	INO	1.26	0.03	0.02	103040
2026-09-02	INO	1.365	0.03	0.00	103880
2026-09-03	INO	1.35	0.03	0.07	103618
2026-09-04	INO	1.42	0.03	0.03	102197
2026-09-08	INO	1.415	0.03	0.06	100069
2026-09-09	INO	1.325	0.03	0.03	100432
2026-09-10	INO	1.28	0.03	0.14	100468
2026-09-11	INO	1.25	0.03	0.02	100596
2026-09-14	INO	1.18	0.03	0.07	101233
2026-09-15	INO	1.155	0.03	0.05	101455
2026-09-16	INO	1.155	0.03	0.32	102296
2026-09-17	INO	1.21	0.03	0.33	102729
2026-09-18	INO	1.23	0.04	0.07	104042
2026-09-21	INO	1.245	0.02	0.04	93492
2026-09-22	INO	1.3	0.02	0.14	94242
2026-09-23	INO	1.255	0.02	0.02	95496
2026-09-24	INO	1.21	0.02	0.23	96627
2026-09-25	INO	1.18	0.02	0.24	97715
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	INO	1.28	77.6	-	-0.73
2026-08-31	INO	1.26	77.6	-	-0.73
2026-09-01	INO	1.33	77.6	-	-0.73
2026-09-02	INO	1.36	77.6	-	-0.73
2026-09-03	INO	1.36	77.6	-	-0.73
2026-09-04	INO	1.42	77.6	-	-0.73
2026-09-08	INO	1.41	77.6	-	-0.73
2026-09-09	INO	1.33	77.6	-	-0.73
2026-09-10	INO	1.28	77.6	-	-0.73
2026-09-11	INO	1.25	77.6	-	-0.73
2026-09-14	INO	1.19	77.6	-	-0.73
2026-09-15	INO	1.15	77.6	-	-0.73
2026-09-16	INO	1.15	77.6	-	-0.73
2026-09-17	INO	1.21	77.6	-	-0.73
2026-09-18	INO	1.24	77.6	-	-0.73
2026-09-21	INO	1.25	77.6	-	-0.73
2026-09-22	INO	1.29	77.6	-	-0.73
2026-09-23	INO	1.24	77.6	-	-0.73
2026-09-24	INO	1.21	77.6	-	-0.73
2026-09-25	INO	1.18	77.6	-	-0.73
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	INO	0.00	-0.41	19.40
2026-08-31	INO	0.00	1.43	19.40
2026-09-01	INO	0.00	1.43	19.40
2026-09-02	INO	0.00	1.43	19.40
2026-09-03	INO	0.00	1.43	19.40
2026-09-04	INO	0.00	1.43	19.40
2026-09-08	INO	0.00	1.43	19.40
2026-09-09	INO	0.00	1.43	19.40
2026-09-10	INO	0.00	1.43	19.40
2026-09-11	INO	0.00	1.43	18.71
2026-09-14	INO	0.00	1.44	18.69
2026-09-15	INO	0.00	1.44	18.69
2026-09-16	INO	0.00	1.44	18.69
2026-09-17	INO	0.00	1.44	18.69
2026-09-18	INO	0.00	1.44	18.69
2026-09-21	INO	0.00	1.44	18.69
2026-09-23	INO	0.00	1.44	18.69
2026-09-24	INO	0.00	1.44	18.69
2026-09-25	INO	0.00	1.44	19.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.07

Avg. EPS Est. Current Quarter

-0.2

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

1.44

Beta

1.61

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.8

Max Drawdown 5-Year %

-99.3

Target Price

3.17

P/E

Forward P/E

PEG

P/S

P/B

22.23

P/Free Cash Flow

EPS

-1.18

Average EPS Est. Cur. Y

-0.73

EPS Next Y. (Est.)

-0.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.6

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.41

EBIT Estimation

◆ INO Healthcare

$1.18

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

8/20

Pullback

23/25

Volume

9/15

Valuation

12/20

TP/AR

1/10

Options

8/10

RSI

47.1

Range 1M

31.1%

Sup Dist

0.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

25/30

Estimates

0/20

Inst/Vol

4/15

Options

8/10

EPS Yr

57.8%

EPS NY

44.1%

52W%

29.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +168.6% upside

Quality

2/30

Valuation

16/30

Growth

19/25

Stability

2/10

LT Trend

4/5

Upside

+168.6%

Quality

INO — P/E HistoricalBiotechnology

Inovio Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 112

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

INO

Latest News

—

Caricamento notizie per INO…

stock quote shares INO – Inovio Pharmaceuticals, Inc. Stock Price stock today

news today INO – Inovio Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch INO – Inovio Pharmaceuticals, Inc. yahoo finance google finance

stock history INO – Inovio Pharmaceuticals, Inc. invest stock market

stock prices INO premarket after hours

ticker INO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: INO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y